Literature DB >> 15276802

Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome.

Thomas G Hampton1, Melissa R Stasko, Ajit Kale, Ivo Amende, Alberto C S Costa.   

Abstract

The segmentally trisomic mouse Ts65Dn is a model of Down syndrome (DS). Gait abnormalities are almost universal in persons with DS. We applied a noninvasive imaging method to quantitatively compare the gait dynamics of Ts65Dn mice (n=10) to their euploid littermates (controls) (n=10). The braking duration of the hind limbs in Ts65Dn mice was prolonged compared to that in control mice (60+/-3 ms vs. 49+/-2 ms, P<.05) at a slow walking speed (18 cm/s). Stride length and stride frequency of forelimbs and hind limbs were comparable between Ts65Dn mice and control mice. Stride dynamics were significantly different in Ts65Dn mice at a faster walking speed (36 cm/s). Stride length was shorter in Ts65Dn mice (5.9+/-0.1 vs. 6.3+/-0.3 cm, P<.05), and stride frequency was higher in Ts65Dn compared to control mice (5.9+/-0.1 vs. 5.3+/-0.1 strides/s, P<.05). Hind limb swing duration was prolonged in Ts65Dn mice compared to control mice (93+/-3 vs. 76+/-3 ms, P<.05). Propulsion of the forelimbs contributed to a significantly larger percentage of stride duration in Ts65Dn mice than in control mice at the faster walking speed. Indices of gait dynamics in Ts65Dn mice correspond to previously reported findings in children with DS. The methods used in the present study provide quantitative markers for genotype and phenotype relationship studies in DS. This technique may provide opportunities for testing the efficacy of therapies for motor dysfunction in persons with DS.

Entities:  

Mesh:

Year:  2004        PMID: 15276802     DOI: 10.1016/j.physbeh.2004.04.006

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  57 in total

1.  NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy.

Authors:  Raquel Gómez-Sintes; José J Lucas
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  The relationship between bone mechanical properties and ground reaction forces in normal and hypermuscular mice.

Authors:  Daniel Schmitt; Ann C Zumwalt; Mark W Hamrick
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2010-07-01

3.  Coordination of steering in a free-trotting quadruped.

Authors:  Eyal Gruntman; Yoav Benjamini; Ilan Golani
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2006-12-05       Impact factor: 1.836

Review 4.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

5.  Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease.

Authors:  Ying Dai; Nichole L Dudek; Qian Li; Stephen C Fowler; Nancy A Muma
Journal:  J Neurosci       Date:  2009-09-16       Impact factor: 6.167

6.  Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.

Authors:  Megan Stringer; Irushi Abeysekera; Jared Thomas; Jonathan LaCombe; Kailey Stancombe; Robert J Stewart; Karl J Dria; Joseph M Wallace; Charles R Goodlett; Randall J Roper
Journal:  Physiol Behav       Date:  2017-05-03

7.  Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.

Authors:  Siv Vingill; David Brockelt; Camille Lancelin; Lars Tatenhorst; Guergana Dontcheva; Christian Preisinger; Nicola Schwedhelm-Domeyer; Sabitha Joseph; Miso Mitkovski; Sandra Goebbels; Klaus-Armin Nave; Jörg B Schulz; Till Marquardt; Paul Lingor; Judith Stegmüller
Journal:  EMBO J       Date:  2016-08-05       Impact factor: 11.598

8.  Using animal models to evaluate the functional consequences of anesthesia during early neurodevelopment.

Authors:  Susan E Maloney; Catherine E Creeley; Richard E Hartman; Carla M Yuede; Charles F Zorumski; Vesna Jevtovic-Todorovic; Krikor Dikranian; Kevin K Noguchi; Nuri B Farber; David F Wozniak
Journal:  Neurobiol Learn Mem       Date:  2018-03-14       Impact factor: 2.877

9.  The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury.

Authors:  Joe E Springer; Ravikumar Rangaswamy Rao; Hyang Ran Lim; Sung Ig Cho; Gyoeng Joon Moon; Hee Young Lee; Eui Jin Park; Jai Sung Noh; Byoung Joo Gwag
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

10.  Inhibition of calpain increases LIS1 expression and partially rescues in vivo phenotypes in a mouse model of lissencephaly.

Authors:  Masami Yamada; Yuko Yoshida; Daisuke Mori; Takako Takitoh; Mineko Kengaku; Hiroki Umeshima; Keizo Takao; Tsuyoshi Miyakawa; Makoto Sato; Hiroyuki Sorimachi; Anthony Wynshaw-Boris; Shinji Hirotsune
Journal:  Nat Med       Date:  2009-09-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.